Kevin E. Healy
26Patents
5h-index
34Co-inventors
69Inventor score
Filing activity: Jan 25, 1996 → Oct 26, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5670161A | Biodegradable stent | Human Necessities | 567 | Expired |
| US6607553B1 | Method for deploying a thermo-mechanically expandable stent | Human Necessities | 184 | Expired |
| US6736842B2 | Thermo-mechanically expandable stent | Human Necessities | 111 | Expired |
| US5723508A | Method of fabricating emulsion freeze-dried scaffold bodies and resulting products | Chemistry; Metallurgy | 36 | Expired |
| US5863650A | Interfacial coatings | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8298606B2 | Methods and compositions for stabilizing the myocardium | Human Necessities | 5 | Active |
| US7985601B2 | Tunable, semi-interpenetrating polymer networks (sIPNS) for medicine and biotechnology | Human Necessities | 5 | Active |
| US10233415B1 | Microfluidics cell culture device | Performing Operations; Transporting | 5 | Active |
| US9428561B2 | Polypeptide-polymer conjugates and methods of use thereof | Human Necessities | 4 | Active |
| US9925237B2 | Polypeptide-polymer conjugates and methods of use thereof | Human Necessities | 3 | Active |
| US10765759B2 | Methods of treating an ocular disease or disorder | Chemistry; Metallurgy | 3 | Active |
| US9415135B2 | Methods and compositions for stabilizing the myocardium | Human Necessities | 3 | Active |
| US10350267B2 | Polypeptide-polymer conjugates and methods of use thereof | Human Necessities | 2 | Active |
| US8501905B2 | Synthetic cell platforms and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US8981046B2 | Synthetic cell platforms and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US8883214B2 | Implantable delivery vehicle for ocular delivery of muscarinic antagonists | Human Necessities | 1 | Active |
| US10851344B2 | Reversible stencils for fabricating micro-tissues | Chemistry; Metallurgy | 1 | Active |
| US11723982B2 | Methods of treating an ocular disease or disorder | Chemistry; Metallurgy | 1 | Active |
| US9827272B2 | Growth factor sequestering and presenting hydrogels | Chemistry; Metallurgy | 0 | Active |
| US10736989B2 | Methods and compositions for stabilizing the myocardium | Human Necessities | 0 | Active |
| US10150948B2 | Compositions and methods for producing and administering brown adipocytes | Chemistry; Metallurgy | 0 | Active |
| US10000582B2 | Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10995225B2 | Macrocyclic polyphenols for universal coatings | Chemistry; Metallurgy | 0 | Active |
| US9492484B2 | Cardiosphere derived cell population and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11291707B2 | Polypeptide-polymer conjugates and methods of use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.